According to the World Health Organization, depression is one of the most frequent mental health disorders and a primary cause of disability in the world (WHO). The gut microbiota may play a role in the development of depression disorders, and the severity of depressed symptoms varies between ethnic groups, according to a Reliable Source.Scientists from the United Kingdom and the Netherlands have revealed that thirteen different species of bacteria that are prevalent in the stomach are connected with symptoms of sadness.
A recent study that was published in Nature CommunicationsReliable Source demonstrates how the bacteria that live in the gut may be responsible for the creation of certain neurotransmitters, such as serotonin and glutamate, which are linked to depression.
Depression is characterized by an ongoing sense of emptiness, sadness, or the inability to experience pleasure. It is still not fully understood what causes depression; however, it is believed that a number of variables are involved, such as changes in neurotransmitter levels in the brain or heredity.
The findings of the study are as follows:
Researchers from Oxford Population Health, in collaboration with other researchers from the Netherlands, carried out this study to evaluate the connection between the make-up and diversity of the microbiota in the gut and the presence of depressive symptoms.
They analyzed the data collected from 1,133 people who took part in the Rotterdam StudyReliable Source. They made it cautious about adjusting for lifestyle factors and medication use as part of their analysis. This was done so that they could draw accurate conclusions. For instance, they only included people who were not currently using any antidepressants in their study.
This was done in order to prevent assessing changes in the gut flora that are a result of the depression rather than a cause of the condition.
A number of different bacteria that were found revealed evidence of possible participation in the process by which individuals manufacture neurotransmitters, in particular those neurotransmitters that are connected to depression such as glutamate.
After that, the researchers used the data gathered in an additional observational study known as the HELIUS study in order to replicate and validate these findings.
The findings of this study might, at some point in the future, pave the way for the creation of innovative therapies for illnesses such as depression.
